HS
PMVP icon

HighVista Strategies’s PMV Pharmaceuticals PMVP Stock Holding History

HighVista Strategies’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23,324
Closed -$278K – 120
2022
Q3 		$278K Hold
23,324
– – 0.16% 97
2022
Q2 		$332K Buy
+23,324
New +$339K 0.2% 90
2022
Q1 		– Sell
-39,777
Closed -$919K – 95
2021
Q4 		$919K Hold
39,777
– – 0.73% 51
2021
Q3 		$1.19M Buy
39,777
+16,019
+67% +$511K 0.78% 39
2021
Q2 		$812K Buy
23,758
+2,880
+14% +$96.2K 0.58% 44
2021
Q1 		$687K Sell
20,878
-1,776
-8% -$70K 0.51% 41
2020
Q4 		$1.39M Buy
+22,654
New +$889K 0.89% 19

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

HighVista Strategies's PMVP Position: Q4 2022 in Review

HighVista Strategies sold out of PMV Pharmaceuticals (PMVP) in Q4 2022, closing a stake of 23,324 shares — an estimated $278K sold.

HighVista Strategies first reported a position in PMVP in Q4 2020 and held it in 7 quarters. The position peaked at $1.39M in Q4 2020. 115 funds tracked by Wall St. Rank hold PMVP as of Q4 2022.

  • HighVista Strategies reported no remaining PMV Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • HighVista Strategies sold 23,324 PMV Pharmaceuticals shares in Q4 2022, an estimated $278K.
  • HighVista Strategies first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 7 quarters.
  • HighVista Strategies's PMV Pharmaceuticals position peaked at $1.39M in Q4 2020.
  • 115 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2022.

Based on HighVista Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.